Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Naja-comp is a homeopathic combination medicinal product produced by Weleda. It is formulated as an oral mixture and contains several homeopathic ingredients, including Naja tripudians (cobra venom) in various potencies. The product is marketed primarily in Germany and other European countries for use in traditional homeopathy, with claimed indications such as support for migraine and circulation. Its mechanism of action follows the principles of homeopathy rather than established pharmacological pathways; thus, it does not have a conventional mechanism of action or molecular target as recognized by modern medicine. The preparation is not prescription-only but is pharmacy-only in some regions[8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Naja-comp.